1. Home
  2. MDAIW vs DRRX Comparison

MDAIW vs DRRX Comparison

Compare MDAIW & DRRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDAIW
  • DRRX
  • Stock Information
  • Founded
  • MDAIW N/A
  • DRRX 1998
  • Country
  • MDAIW United States
  • DRRX United States
  • Employees
  • MDAIW 78
  • DRRX N/A
  • Industry
  • MDAIW Medical/Dental Instruments
  • DRRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • MDAIW Health Care
  • DRRX Health Care
  • Exchange
  • MDAIW Nasdaq
  • DRRX Nasdaq
  • Market Cap
  • MDAIW N/A
  • DRRX N/A
  • IPO Year
  • MDAIW N/A
  • DRRX 2000
  • Fundamental
  • Price
  • MDAIW $0.54
  • DRRX $0.69
  • Analyst Decision
  • MDAIW
  • DRRX Hold
  • Analyst Count
  • MDAIW 0
  • DRRX 1
  • Target Price
  • MDAIW N/A
  • DRRX N/A
  • AVG Volume (30 Days)
  • MDAIW 35.6K
  • DRRX 71.7K
  • Earning Date
  • MDAIW 02-27-2025
  • DRRX 08-12-2025
  • Dividend Yield
  • MDAIW N/A
  • DRRX N/A
  • EPS Growth
  • MDAIW N/A
  • DRRX N/A
  • EPS
  • MDAIW N/A
  • DRRX N/A
  • Revenue
  • MDAIW $27,264,000.00
  • DRRX $1,856,000.00
  • Revenue This Year
  • MDAIW N/A
  • DRRX N/A
  • Revenue Next Year
  • MDAIW N/A
  • DRRX $673.00
  • P/E Ratio
  • MDAIW N/A
  • DRRX N/A
  • Revenue Growth
  • MDAIW 44.52
  • DRRX 79.84
  • 52 Week Low
  • MDAIW $0.08
  • DRRX $0.48
  • 52 Week High
  • MDAIW $0.90
  • DRRX $1.74
  • Technical
  • Relative Strength Index (RSI)
  • MDAIW N/A
  • DRRX 64.17
  • Support Level
  • MDAIW N/A
  • DRRX $0.59
  • Resistance Level
  • MDAIW N/A
  • DRRX $0.76
  • Average True Range (ATR)
  • MDAIW 0.00
  • DRRX 0.06
  • MACD
  • MDAIW 0.00
  • DRRX 0.02
  • Stochastic Oscillator
  • MDAIW 0.00
  • DRRX 73.85

About MDAIW Spectral AI Inc.

Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.

Share on Social Networks: